The certificate on the promotional page at the State Intellectual Property Office corresponds to this patent:
[Invention Authorization]? Pharmaceutical composition for treating acute and chronic rhinitis and its preparation method
Authorization announcement number: CN100389792C
Authorization announcement date: 2008.05.28
Application number: 200510001994X
Application date: 2005.01.17
Patentee: Foshan Dezhong Pharmaceutical Co., Ltd.
Inventor: Cui Fangxiang; Yang Xionghui
Address: Foping Road, Foshan City, Guangdong Province 528000 No. 89
Category number: A61K36/575 (2006.01);?All
Abstract: The present invention discloses a new Chinese and Western medicine composition for the treatment of acute and chronic rhinitis , the pharmaceutical composition is prepared from the following raw materials: ephedrine hydrochloride, baicalin, magnolia oil, borneol, and honeysuckle. The pharmaceutical composition of the present invention can be prepared into any suitable clinically acceptable preparation according to conventional methods in the art, preferably nasal drops, aerosols and sprays. Clinical efficacy observation of the pharmaceutical composition of the present invention has confirmed that it can treat acute and chronic rhinitis and colds caused by wind-heat accumulating in the lungs. Nasal congestion, runny nose, headache, burning sensation in the nasal cavity, dry mouth, sore throat, alternating nasal congestion, sometimes mild and sometimes severe, It has significant curative effect on clinical symptoms such as blunted sense of smell, and the clinical medication is safe and has no toxic or side effects.